Genprex, Inc. – NASDAQ:GNPX
Founder-led company
Genprex stock price today
$0.173
-0.70
-80.19%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 6 hours
Genprex stock price monthly change
-54.43%
month
Genprex stock price quarterly change
-54.43%
quarter
Genprex stock price yearly change
+302.30%
year
Genprex key metrics
Market Cap | 7.84M |
Enterprise value | N/A |
P/E | -1.74 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 1.72 |
PEG ratio | -0.02 |
EPS | -19.18 |
Revenue | N/A |
EBITDA | -27.77M |
Income | -27.62M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeGenprex stock price history
Genprex stock forecast
Genprex financial statements
| Jun 2023 | 0 | -7.98M | |
|---|---|---|---|
| Sep 2023 | 0 | -7.74M | |
| Dec 2023 | 23.15K | -5.92M | -25607.89% |
| Mar 2024 | 0 | -5.96M |
| Mar 2024 | 0 | -5.96M | |
|---|---|---|---|
| Sep 2025 | 0 | -965.83K | |
| Oct 2025 | 0 | -1.03M | |
| Dec 2025 | 0 | -938.57K |
Analysts Price target
Financials & Ratios estimates
| 2022-11-14 | -0.12 | -0.13 |
|---|
| Jun 2023 | 15911119 | 3.86M | 24.26% |
|---|---|---|---|
| Sep 2023 | 16643625 | 4.33M | 26.06% |
| Dec 2023 | 10670592 | 3.25M | 30.5% |
| Mar 2024 | 12564591 | 3.80M | 30.31% |
| Jun 2023 | -8.10M | -20K | 0 |
|---|---|---|---|
| Sep 2023 | -4.73M | -21.75K | 6.51M |
| Dec 2023 | -4.96M | -9.83K | 10 |
| Mar 2024 | -5.29M | -15.82K | 6.79M |
Genprex alternative data
| Aug 2023 | 28 |
|---|---|
| Sep 2023 | 30 |
| Oct 2023 | 30 |
| Nov 2023 | 30 |
| Dec 2023 | 31 |
| Jan 2024 | 31 |
| Feb 2024 | 31 |
| Mar 2024 | 31 |
| Apr 2024 | 31 |
| May 2024 | 26 |
| Jun 2024 | 26 |
| Jul 2024 | 26 |
Genprex other data
2.28%
-6.29%
of GNPX is owned by hedge funds
23
-21
1.07M
-2.96M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Apr 2023 | 39000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | VACZY CATHERINE M officer: EVP GC C.. | Common Stock | 20,000 | $1.07 | $21,480 | ||
Purchase | VARNER JOHN RODNEY director, officer.. | Common Stock | 19,000 | $1.06 | $20,045 | ||
Option | CONFER RYAN M. officer: Chief Financial Officer | Stock Option (right to buy) | 116,973 | $0.02 | $1,755 | ||
Option | CONFER RYAN M. officer: Chief Financial Officer | Common Stock | 116,973 | $0.02 | $1,755 | ||
Purchase | LONGNECKER BRENT M director | Common Stock | 15,000 | $4.15 | $62,250 | ||
Purchase | VARNER JOHN RODNEY director, officer.. | Common Stock | 1,800 | N/A | N/A | ||
Purchase | PHAM JULIEN L officer: President & COO | Common Stock | 500 | N/A | N/A | ||
Purchase | NANCE CHRISTY M. 10 percent owner | Common Stock | 50,000 | N/A | N/A | ||
Purchase | ROTH JACK A 10 percent owner | Common Stock | 40,000 | $5 | $200,000 | ||
Purchase | VARNER JOHN RODNEY director, officer.. | Common Stock | 10,000 | $5 | $50,000 |
| Insider | Compensation |
|---|---|
| Mr. John Rodney Varner (1957) Co, Founder, Pres, Chief Executive Officer, Sec. & Chairman | $750,940 |
| Ms. Catherine M. Vaczy (1961) Executive Vice President, Gen. Counsel & Chief Strategy Officer | $646,020 |
Mr. Ryan M. Confer M.S. (1982) Chief Financial Officer | $522,530 |
-
What's the price of Genprex stock today?
One share of Genprex stock can currently be purchased for approximately $0.17.
-
When is Genprex's next earnings date?
Unfortunately, Genprex's (GNPX) next earnings date is currently unknown.
-
Does Genprex pay dividends?
No, Genprex does not pay dividends.
-
How much money does Genprex make?
Genprex has a market capitalization of 7.84M. Genprex made a loss 30.86M US dollars in net income (profit) last year or -$0.13 on an earnings per share basis.
-
What is Genprex's stock symbol?
Genprex, Inc. is traded on the NASDAQ under the ticker symbol "GNPX".
-
What is Genprex's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Genprex?
Shares of Genprex can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Genprex's key executives?
Genprex's management team includes the following people:
- Mr. John Rodney Varner Co, Founder, Pres, Chief Executive Officer, Sec. & Chairman(age: 68, pay: $750,940)
- Ms. Catherine M. Vaczy Executive Vice President, Gen. Counsel & Chief Strategy Officer(age: 64, pay: $646,020)
- Mr. Ryan M. Confer M.S. Chief Financial Officer(age: 43, pay: $522,530)
-
Is Genprex founder-led company?
Yes, Genprex is a company led by its founder Mr. John Rodney Varner.
-
How many employees does Genprex have?
As Jul 2024, Genprex employs 26 workers, which is 16% less then previous quarter.
-
When Genprex went public?
Genprex, Inc. is publicly traded company for more then 7 years since IPO on 29 Mar 2018.
-
What is Genprex's official website?
The official website for Genprex is genprex.com.
-
Where are Genprex's headquarters?
Genprex is headquartered at 3300 Bee Cave Road, Austin, TX.
-
How can i contact Genprex?
Genprex's mailing address is 3300 Bee Cave Road, Austin, TX and company can be reached via phone at 877 774 4679.
Genprex company profile:
Genprex, Inc.
genprex.comExchange:
NASDAQ
Full time employees:
21
Industry:
Biotechnology
Sector:
Healthcare
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
3300 Bee Cave Road
Austin, TX 78746
Austin, TX 78746
CIK: 0001595248
ISIN: US3724462037
CUSIP: 372446104
